{
    "code": "02022732",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022732",
    "time": "2021-12-17 03:22:58",
    "許可證字號": "衛署藥輸字第022732號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/01\/05",
    "發證\/登錄日期": "89\/01\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202273204",
    "中文品名": "福達樂靜脈凍晶注射劑",
    "英文品名": "FLUDARA LYOPHILIZED IV INJECTION",
    "適應症": "用於B細胞慢性淋巴性白血病(CLL)病患的起始治療及CLL與低惡性度非何杰金氏淋巴瘤(LG-NHL)病患，歷經至少一種標準內容的烷化基藥劑(ALKYLATING AGENT)的治療方法都無效，或治療後雖有效但隨後疾病又繼續惡化的病人。以本品作為第一線治療，只適用於重度病患即評估為RAI III\/IV階段(BINET C級)或RAI I\/II (BINET A\/B級)但併有疾病相關症候或病情持續惡化的病人。",
    "劑型": "243凍晶注射劑",
    "包裝": "每小瓶50公絲裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FLUDARABINE PHOSPHATE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FGB0200000  GENZYME LIMITED",
            "製造廠廠址": "37 HOLLANDS ROAD, HAVERHILL, SUFFOLK, CB9 8PU, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001710",
            "成分名稱": "FLUDARABINE PHOSPHATE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Fludara Inj_vial-104-09-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022732&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Fludara IV C labeling CCDS v26 + new packaging site_20150113-110-07-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022732&Seq=021&Type=9"
        },
        {
            "title": "福達樂靜脈凍晶注射劑_20140730-2014-07-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022732&Seq=019&Type=9"
        },
        {
            "title": "817588(iss1)_Pathed_May'21 validated-110-06-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022732&Seq=002&Type=8"
        },
        {
            "title": "Fludara Inj_box-104-09-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022732&Seq=001&Type=8"
        }
    ]
}